ExodusPoint Capital Management’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$343K Buy
2024
Q4
Sell
2024
Q3
$81K Buy
2021
Q3
Sell
2021
Q2
$135K Buy
2019
Q2
Sell
2019
Q1
$362K Buy
2018
Q4
$119K Buy